TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.

Carlos A Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.